PUBLISHED DATE : Dec 2022 | Pages : 335
Fill out your details & get your free sample
The Global Pharmaceutical Packaging Market Size, Share, And Growth Forecast By:
Industry Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share, & Forecast 2022-2027
335 Pages
92 Tables
171 Charts
5 Regions
18 Countries
30 Companies
4 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 106.37 BILLION |
| Market Size (2021) | USD 81 BILLION |
| CAGR (2021-2027) | 4.65% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Type, Material, End-User, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| KEY VENDORS | Amcor, Aptar Group, Berry Global, Gerresheimer, and WestRock |
The global pharmaceutical packaging market is expected to grow at a CAGR of 4.65% and will cross USD 106.37 billion by 2027 from USD 81 billion in 2021 from 2021-2027. The demand for advanced and innovative solutions, such as self-administered drug delivery devices, is rising in high-income countries, bringing lucrative opportunities for the pharmaceutical packaging market. In addition, diseases have increased in recent years, including various types of flu, the COVID-19 pandemic, monkeypox, and more. Rising healthcare expenses and growing consumer awareness regarding healthier lifestyles drive the industry.
The growing chronic disease prevalence, growth in the biologics market, and technological advancements are anticipated to propel the market. However, fluctuations in raw material prices, emerging markets such as newly developed drugs, and lack of compliance with regulatory standards hamper the market's growth.
Driving Factors In The Global Pharmaceutical Packaging Market
Active Mergers And Acquisitions Playing A Key Role In Smooth Functioning For The Growth of The Global Pharmaceutical Packaging Market
Increasing Virtual Consultations Is Anticipating The Growth Of Aluminium-Based Drug Packaging
High-income countries from North America and Europe are witnessing an increased adoption of virtual visits and e-prescriptions, leading to a large dependency on the home delivery of medicines. The home delivery of goods is one of the significant challenges for pharmaceutical packaging companies as the customers are not aware of the proper disposal of packaged products and materials, leading to a substantial environmental impact. Due to this concern, aluminum packaging is one of the improved solutions to overcome this issue.
Eco-Friendly Packaging
Around 85% of the waste produced by healthcare operations, including pharmaceutical and medical equipment packaging, is non-hazardous and, therefore, exhibits the potential to be replaced by other eco-friendly and reusable alternatives, enabling significant cost savings. Many pharma companies are shifting to sustainable packaging that uses recyclable materials and biodegradable plastics. Sustainable pharmaceutical packaging is expected to grow during the forecast period. PET (polyethylene terephthalate) is a recyclable plastic material. It is a very versatile material for the manufacturing of pharmaceutical products packaging. It has a good carbon dioxide (CO2), oxygen, and moisture barrier, allowing it to store liquids and solids as fresh as possible. Europe is expected to lead the growth in the biodegradable pharmaceutical packaging market. In Europe, the key players in the global biodegradable pharmaceutical packaging market include Gerresheimer, Berry Global, International Paper, and Amcor.
Introduction Of Anti-Counterfeiting Features
A counterfeit pharmaceutical product is deliberately and fraudulently mislabelled concerning identity. Counterfeit pharmaceutical products may include products with correct ingredients, wrong ingredients, without active ingredients, wrong ingredients with the inaccurate quantity of an active ingredient, or with fake packaging. The global pharmaceutical packaging market has witnessed a major challenge with the growing incidences of counterfeit products. As a result, many manufacturers in recent years have introduced several anti-counterfeiting features to fight the distribution of counterfeit pharmaceutical products. These anti-counterfeiting features include using thermochromic inks for labeling, holograms, QR code, RFID labels, and many more. Some innovations include child-resistant, senior-friendly & high barrier, unit-dose, multi-dose, and specialty film packaging.
COVID-19 has shown adverse effects on the global healthcare industry and has thus contributed to hindering the growth of the pharmaceutical packaging market. The COVID-19 impact on the pharmaceutical sector included changes in demand, regulation adjustments, R&D process changes, and supply chain restructuring. In addition, trends such as industry slow-down, delays in approvals, modifying clinical trial methods, self-sufficiency in the pharmaceutical product supply chain, and variations in consumption of health & nutritional products are expected to be some of the long-term impacts of the COVID-19 pandemic on the pharmaceutical industry globally.
During the pandemic, pharma packaging companies witnessed stable revenue growth in 2020. Major pharmaceutical packaging companies increased their production capacity to support the increased demand for pre-filled syringes, blister packs, ampoules/vials, bags, cartridges, containers, and bottles. This was mainly due to a surge in demand for COVID-19-related medications and vaccines. Moreover, pharmaceutical packaging for biologics, sterile packaging, smart packaging, patient focus packaging, cleanroom expansion, and others are anticipated to drive the global pharmaceutical packaging market in the long term.
INSIGHTS BY TYPE SEGMENTATION
Primary pharmaceutical packaging segmentation accounted for the largest market share of 70.20% in 2021, owing to the growing demand for blister packs, bottles, vials, ampoules, pouches, sachets, and bags. The blister packs account for a significant revenue share of 35.23% in 2021 in the global pharmaceutical packaging market due to the high demand for prescription and non-prescription medications/drugs, among which the demand for generic drugs is the highest among LMIC. Although the pharmaceutical sector accounts for the major share of the global market, a consistent surge in blister packaging demand contributes to its cost-effectiveness. The evolution from simple bulk packaging materials toward ready-to-sterilize (RTS) primary packaging components and systems is the dominant trend in the primary packaging segment of the market
Innovations in secondary pharmaceutical packaging include developing child-resistant (CR) cartons, tamper-evident (TE) cartons, and cold-chain packaging. The secondary packaging segment accounted for 20.30% of the global pharmaceutical packaging market share.
Tertiary packaging is used for the safe handling and smooth transportation of products. Examples of tertiary packaging include plastic bags, shrink wraps, and cardboard boxes. The increasing trend of e-pharmacy will likely further the adoption of tertiary packaging in the pharmaceutical packaging market. It is expected to grow with a CAGR of 3.96% during the forecast period.
INSIGHTS FROM MATERIAL SEGMENTATION
Paper materials accounted for the highest revenue share of 39.36% in 2021 in the global pharmaceutical packaging market due to their increasing demand in secondary and tertiary packaging, low cost, and increasing focus on recyclable and eco-friendly materials. Demand for paper-based packaging, both corrugated and folding cartons, has been rising across Europe during the last few years owing to its largest pharmaceutical market and the largest exporter of pharmaceuticals. WestRock Company is one of the leading manufacturers of paper-based packaging.
Plastics held the third largest share in 2021 in the pharmaceutical packaging market by material segmentation. It is expected to grow at the highest CAGR of 4.94% from 2022-2027, powered due its growing demand in all three packaging types. In addition, plastics are widely used in packaging because of their versatility, flexibility, and cost-effectiveness. However, due to its non-decomposable properties and its ban for use because of its environmental issues as it produces a high quantity of greenhouse gases has banned its use in several countries. As a result, recyclable plastics are in high demand. The most widely used-recyclable plastics in pharmaceutical packaging include PET, HDPE, and PP, among which PET is the most commonly recycled plastic worldwide, followed by HDPE. Several governments and companies are developing initiatives to use recycled plastics as packaging material for pharmaceutical medicines and supplies.
INSIGHTS FROM END-USER SEGMENTATION
Pharmaceutical companies account for the highest market share of 48.18% in the global pharmaceutical packaging market by end-user segment. It is expected to grow at the highest CAGR of 5.10% during the forecast period. The highest revenue share of pharma companies is because pharmaceutical companies are the primary source for the pharmaceutical packaging market. As the demand for pharmaceuticals continues to grow, the need for packaging has also increased significantly.
North America accounts for 36% of the global pharmaceutical packaging market share. The growing pharmaceutical sales in North America are the major driving factor for the pharmaceutical packaging market in the region. North America, in particular the US, will continue to be the largest pharma packaging market long term due to the advanced drug-producing sector. The US market is expected to maintain moderate growth due to the increasing aging population, robust innovations, and increasing consumer demand for sophisticated packaging.
Emerging markets such as Brazil, China, and India are anticipated to grow at the fastest rate, which can be attributed to their large population and demographic factors such as a growing young population and longer life expectancy. APAC is estimated to show the highest growth of 5.01% during the forecast period. The pharmaceutical industry is booming, especially in developing countries such as China, India, and Brazil, as well as in developed countries such as the US, UK, and Germany. According to the India Brand Equity Foundation (IBEF), India is the largest provider of generic drugs globally. At the same time, the Indian pharmaceutical sector supplies around 50% of the global demand for several vaccines, 40% demand for generic drugs in the US, and 25% of all tablets in the UK.
The global pharmaceutical packaging market is highly dynamic and competitive, with several international, regional, and local vendors offering a diverse and comprehensive range of pharmaceutical packaging products with wide applications. The key players in the industry are Berry Global, Amcor, Gerresheimer, WestRock, and AptarGroup.The industry also has the presence of prominent players, some of which include ACG, Airnov, Borosil, CCL Industries, and Drug Plastics Group.
Vendors' Activities In The Pharmaceutical Packaging Market Include:
A Diverse Range of Pharmaceutical Packaging Products Offered In The Industry
Frequently Asked Questions
How big is the pharmaceutical packaging market?
The global pharmaceutical packaging market size was valued at USD 81.00 billion in 2021 and is expected to surpass USD 106.37 billion by 2027. The growth can be attributable to the surge in demand for pharmaceutical packaging in emerging economies such as Brazil, India, and China. In addition, rising healthcare expenses and growing consumer awareness regarding healthier lifestyles drive the industry.
What is the growth rate of the global pharmaceutical packaging market?
The global pharmaceutical packaging market share is growing at a CAGR of 4.65% from 2021-2027.
Who are the key players in the global pharmaceutical packaging market?
Amcor, Aptar Group, Berry Global, Gerresheimer, and WestRock are the key players in the global pharmaceutical packaging market.
Which region will dominate the global pharmaceutical packaging market?
North America accounts for the highest pharmaceutical packaging market share, attributable to growing pharmaceutical demand, a growing aging population, robust innovations, and increasing consumer demand for sophisticated packaging.
What are the factors driving the pharmaceutical packaging market?
Growing demand for pharmaceuticals, increasing demand for primary pharmaceutical packaging, and rising demand for flexible packaging are the key factors driving the global pharmaceutical packaging market.
The global pharmaceutical packaging market is expected to grow at a CAGR of approximately 4.65% from 2021 to 2027.
The following factors are likely to contribute to the growth of the global pharmaceutical packaging market during the forecast period:
Base Year: 2021
Forecast Year: 2022-2027
The report considers the present scenario of the global pharmaceutical packaging market and its market dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The study covers both the demand and supply sides of the market. It also profiles and analyzes leading companies and several other prominent companies operating in the market.
Key Vendors
Other Prominent Vendors
Segmentation by Type
Segmentation by Material
Segmentation by End-User
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY TYPE
4.3.2 MARKET SEGMENTATION BY MATERIAL
4.3.3 MARKET SEGMENTATION BY END USER
4.3.4 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
8 PREMIUM INSIGHTS
8.1 MARKET SCENARIO
9 MARKET OPPORTUNITIES & TRENDS
9.1 INCREASE IN FOCUS ON ECO-FRIENDLY PACKAGING
9.2 IMPLEMENTATION OF NANOTECHNOLOGY IN PHARMACEUTICAL PACKAGING
9.3 ADVANCES IN PACKAGING MATERIALS
10 MARKET GROWTH ENABLERS
10.1 RISE IN DEMAND FOR PHARMACEUTICALS
10.2 HIGH DEMAND FOR PRIMARY PHARMACEUTICAL PACKAGING
10.3 SURGE IN DEMAND FOR FLEXIBLE PACKAGING
11 MARKET RESTRAINTS
11.1 SURGE IN HOME DELIVERY OF PHARMACEUTICAL PRODUCTS
11.2 STRINGENT REGULATORY STANDARDS
11.3 VOLATILITY IN RAW MATERIAL PRICES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.2.1 INSIGHT BY TYPE
12.2.2 INSIGHT BY MATERIAL
12.2.3 INSIGHT BY END USER
12.2.4 INSIGHT BY GEOGRAPHY
12.3 FIVE FORCES ANALYSIS
12.3.1 THREAT OF NEW ENTRANTS
12.3.2 BARGAINING POWER OF SUPPLIERS
12.3.3 BARGAINING POWER OF BUYERS
12.3.4 THREAT OF SUBSTITUTES
12.3.5 COMPETITIVE RIVALRY
13 TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 PRIMARY
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 BLISTER PACKS
13.3.4 MARKET SIZE & FORECAST
13.3.5 BOTTLES
13.3.6 MARKET SIZE & FORECAST
13.3.7 VIALS
13.3.8 MARKET SIZE & FORECAST
13.3.9 AMPOULES
13.3.10 MARKET SIZE & FORECAST
13.3.11 OTHERS
13.3.12 MARKET SIZE & FORECAST
13.3.13 MARKET BY GEOGRAPHY
13.4 SECONDARY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 MARKET BY GEOGRAPHY
13.5 TERTIARY
13.5.1 MARKET OVERVIEW
13.5.2 MARKET SIZE & FORECAST
13.5.3 MARKET BY GEOGRAPHY
14 MATERIAL
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 PAPER
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MARKET BY GEOGRAPHY
14.4 GLASS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 MARKET BY GEOGRAPHY
14.5 PLASTIC
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 MARKET BY GEOGRAPHY
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 MARKET BY GEOGRAPHY
15 END USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 PHARMACEUTICAL COMPANIES
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 MARKET BY GEOGRAPHY
15.4 CMOS/CDMOS
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 MARKET BY GEOGRAPHY
15.5 OTHERS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 MARKET BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.3 NORTH AMERICA: TYPE
17.4 NORTH AMERICA: MATERIAL
17.5 NORTH AMERICA: END USER
17.6 KEY COUNTRIES
17.6.1 US: MARKET SIZE & FORECAST
17.6.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.3 EUROPE: TYPE
18.4 EUROPE: MATERIAL
18.5 EUROPE: END USER
18.6 KEY COUNTRIES
18.6.1 GERMANY: MARKET SIZE & FORECAST
18.6.2 UK: MARKET SIZE & FORECAST
18.6.3 FRANCE: MARKET SIZE & FORECAST
18.6.4 ITALY: MARKET SIZE & FORECAST
18.6.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.3 APAC: TYPE
19.4 APAC: MATERIAL
19.5 APAC: END USER
19.6 KEY COUNTRIES
19.6.1 CHINA: MARKET SIZE & FORECAST
19.6.2 JAPAN: MARKET SIZE & FORECAST
19.6.3 SOUTH KOREA: MARKET SIZE & FORECAST
19.6.4 INDIA: MARKET SIZE & FORECAST
19.6.5 AUSTRALIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.3 LATIN AMERICA: TYPE
20.4 LATIN AMERICA: MATERIAL
20.5 LATIN AMERICA: END USER
20.6 KEY COUNTRIES
20.6.1 BRAZIL: MARKET SIZE & FORECAST
20.6.2 MEXICO: MARKET SIZE & FORECAST
20.6.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.3 MIDDLE EAST & AFRICA: TYPE
21.4 MIDDLE EAST & AFRICA: MATERIAL
21.5 MIDDLE EAST & AFRICA: END USER
21.6 KEY COUNTRIES
21.6.1 TURKEY: MARKET SIZE & FORECAST
21.6.2 SAUDI ARABIA: MARKET SIZE & FORECAST
21.6.3 SOUTH AFRICA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 AMCOR
22.2.2 APTARGROUP
22.2.3 BERRY GLOBAL
22.2.4 GERRESHEIMER
22.2.5 WESTROCK
23 KEY COMPANY PROFILES
23.1 AMCOR
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 APTARGROUP
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 BERRY GLOBAL
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 GERRESHEIMER
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
23.5 WESTROCK
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.5.3 KEY STRATEGIES
23.5.4 KEY STRENGTHS
23.5.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 ACG
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 AIRNOV
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 AVI GLOBAL PLAST
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 BD
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 BILCARE
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 BOROSIL
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 CCL INDUSTRIES
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 COESIA
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 DRUG PLASTICS GROUP
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 DWK LIFE SCIENCES
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 LOG
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 MEGHMANI GROUP
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 NEELAM GLOBAL
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 NOLATO
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 NEMERA
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 POLYCINE
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 RENOLIT
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 SCHUR FLEXIBLES HOLDING
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 SPECIALTY POLYFILMS
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 SGD PHARMA
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
24.21 SCHOTT
24.21.1 BUSINESS OVERVIEW
24.21.2 PRODUCT OFFERINGS
24.22 SIPPEX IV BAGS
24.22.1 BUSINESS OVERVIEW
24.22.2 PRODUCT OFFERINGS
24.23 SUPER OLEFINS
24.23.1 BUSINESS OVERVIEW
24.23.2 PRODUCT OFFERINGS
24.24 WEST PHARMACEUTICAL SERVICES
24.24.1 BUSINESS OVERVIEW
24.24.2 PRODUCT OFFERINGS
24.25 WIHURI GROUP
24.25.1 BUSINESS OVERVIEW
24.25.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 MARKET BY GEOGRAPHY
26.2 MARKET BY TYPE
26.3 MARKET BY TYPE (PRIMARY)
26.4 MARKET BY MATERIAL
26.5 MARKET BY END USER
26.6 NORTH AMERICA BY TYPE
26.7 NORTH AMERICA BY TYPE (PRIMARY)
26.8 NORTH AMERICA BY MATERIAL
26.9 NORTH AMERICA BY END USER
26.10 EUROPE BY TYPE
26.11 EUROPE BY TYPE (PRIMARY)
26.12 EUROPE BY MATERIAL
26.13 EUROPE BY END USER
26.14 APAC BY TYPE
26.15 APAC BY TYPE ( PRIMARY)
26.16 APAC BY MATERIAL
26.17 APAC BY END USER
26.18 LATIN AMERICA BY TYPE
26.19 LATIN AMERICA BY TYPE (PRIMARY)
26.20 LATIN AMERICA BY MATERIAL
26.21 LATIN AMERICA BY END USER
26.22 MIDDLE EAST & AFRICA BY TYPE
26.23 MIDDLE EAST & AFRICA BY TYPE (PRIMARY)
26.24 MIDDLE EAST & AFRICA BY MATERIAL
26.25 MIDDLE EAST & AFRICA BY END USER
27 APPENDIX
27.1 ABBREVIATIONS
EXHIBIT 1 SEGMENTATION OF THE GLOBAL PHARMACEUTICAL PACKAGING MARKET
EXHIBIT 2 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 3 IMPACT OF SURGE IN FOCUS ON ECO-FRIENDLY PACKAGING
EXHIBIT 4 GLOBAL PRODUCTION CAPACITIES OF BIOPLASTICS (1,000 TONNES)
EXHIBIT 5 IMPACT OF IMPLEMENTATION OF NANOTECHNOLOGY IN PHARMACEUTICAL PACKAGING
EXHIBIT 6 MARKET VALUE OF NANOTECHNOLOGY WORLDWIDE 2012–2020 ($ BILLION)
EXHIBIT 7 IMPACT OF ADVANCES IN PACKAGING MATERIALS
EXHIBIT 8 IMPACT OF RISE IN DEMAND FOR PHARMACEUTICALS
EXHIBIT 9 RANKING OF INDUSTRIAL SECTORS BY OVERALL SECTOR R&D INTENSITY (R&D AS PERCENTAGE OF NET SALES) 2019
EXHIBIT 10 AGGREGATE VALUE OF GLOBAL PHARMACEUTICAL INDUSTRY 2003–2021 ($ TRILLIONS)
EXHIBIT 11 IMPACT OF HIGH DEMAND FOR PRIMARY PHARMACEUTICAL PACKAGING
EXHIBIT 12 MARKET SHARE OF GLOBAL CELL AND GENE THERAPY DRUG DELIVERY DEVICES 2019
EXHIBIT 13 TYPES OF PRIMARY PHARMACEUTICAL PACKAGING
EXHIBIT 14 INJECTABLES PACKAGING BY STANDALONE OR INTEGRATED STATUS 2019
EXHIBIT 15 IMPACT OF SURGE IN DEMAND FOR FLEXIBLE PACKAGING
EXHIBIT 16 ADVANTAGES OF FLEXIBLE PACKAGING
EXHIBIT 17 SHARE OF FLEXIBLE PACKAGING BY APPLICATION IN US (EXCLUDING FOOD) 2021
EXHIBIT 18 REVENUE OF AMCOR COMPANY IN RIGID AND FLEXIBLE PACKAGING 2019–2021 ($ MILLION)
EXHIBIT 19 SALES OF MAJOR FLEXIBLE AND RIGID PACKAGING PRODUCTS OF AMCOR 2021 ($ MILLION)
EXHIBIT 20 IMPACT OF SURGE IN HOME DELIVERY FOR PHARMACEUTICAL PRODUCTS
EXHIBIT 21 IMPACT OF STRINGENT REGULATORY STANDARDS
EXHIBIT 22 IMPACT OF VOLATILITY IN RAW MATERIAL PRICES
EXHIBIT 23 GLOBAL PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 1 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021 & 2027 (%)
EXHIBIT 2 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021 & 2027 (%)
EXHIBIT 3 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER 2021 & 2027 (%)
EXHIBIT 4 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY 2021 & 2027 (%)
EXHIBIT 5 FIVE FORCES ANALYSIS 2021
EXHIBIT 6 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 7 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PRODUCT
EXHIBIT 8 PHARMACEUTICAL PACKAGING MARKET BY TYPE: MARKET OVERVIEW
EXHIBIT 9 PHARMACEUTICAL PACKAGING MARKET BY TYPE: GROWTH IMPACT
EXHIBIT 10 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 11 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE: ABSOLUTE GROWTH (%)
EXHIBIT 12 GLOBAL PRIMARY PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 13 GLOBAL PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 14 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY BLISTER PACKS 2021–2027 ($ BILLION)
EXHIBIT 15 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY BOTTLES 2021–2027 ($ BILLION)
EXHIBIT 16 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY VIALS 2021–2027 ($ BILLION)
EXHIBIT 17 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY AMPOULES 2021–2027 ($ BILLION)
EXHIBIT 18 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 19 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 20 GLOBAL SECONDARY PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 21 GLOBAL SECONDARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 22 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 23 GLOBAL TERTIARY PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 24 GLOBAL TERTIARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 25 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 26 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 27 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL
EXHIBIT 28 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL: MARKET OVERVIEW
EXHIBIT 29 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL: GROWTH IMPACT
EXHIBIT 30 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 31 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL: ABSOLUTE GROWTH (%)
EXHIBIT 32 GLOBAL CONSUMPTION BY PAPER CATEGORY 2018 ( TONNES) (%)
EXHIBIT 33 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PAPER: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PAPER 2021–2027 ($ BILLION)
EXHIBIT 35 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 36 GLASS PROS AND CONS IN PARENTERAL PACKAGING
EXHIBIT 37 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GLASS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GLASS 2021–2027 ($ BILLION)
EXHIBIT 39 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 40 DIFFERENCE BETWEEN THERMOPLASTICS AND THERMOSETS
EXHIBIT 41 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PLASTIC: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 42 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PLASTIC 2021–2027 ($ BILLION)
EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 44 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHER MATERIALS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHER MATERIALS 2021–2027 ($ BILLION)
EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 47 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 48 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER
EXHIBIT 49 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER: MARKET OVERVIEW
EXHIBIT 50 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER: GROWTH IMPACT
EXHIBIT 51 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 52 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER: ABSOLUTE GROWTH (%)
EXHIBIT 53 LEADING COUNTRIES IN GENERICS MARKET 2019
EXHIBIT 54 TOP 20 BRANDED PHARMACEUTICAL PLAYERS RANKED BY ENTERPRISE VALUE ($ BILLION) 2021
EXHIBIT 55 PATENT EXPIRIES & GENERICS OPPORTUNITIES 2020–2026
EXHIBIT 56 PATENTS EXPIRED BETWEEN 2020 AND 2026
EXHIBIT 57 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PHARMACEUTICAL COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 58 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY PHARMACEUTICAL COMPANIES 2021–2027 ($ BILLION)
EXHIBIT 59 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 60 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY CMOS/CDMOS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 61 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY CMOS/CDMOS 2021–2027 ($ BILLION)
EXHIBIT 62 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 63 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHER END USERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 64 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY OTHER END USERS 2021–2027 ($ BILLION)
EXHIBIT 65 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 66 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 67 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY
EXHIBIT 68 GLOBAL PHARMACEUTICALS MARKET 2003–2020 ($ TRILLIONS)
EXHIBIT 69 GEOGRAPHICAL BREAKDOWN (BY MAIN MARKETS) OF SALES OF NEW MEDICINES LAUNCHED BETWEEN 2015 & 2020 (%)
EXHIBIT 70 ANNUAL GROWTH RATE FOR PHARMACEUTICAL R&D EXPENDITURE 2006–2020 (%)
EXHIBIT 71 GLOBAL PLASTIC PRODUCTION 2016–2020 (MT)
EXHIBIT 72 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY: INCREMENTAL GROWTH ($ BILLION)
EXHIBIT 73 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY: ABSOLUTE GROWTH (%)
EXHIBIT 74 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 75 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 76 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 77 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 78 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 79 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 80 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 81 PHARMACEUTICAL SALES IN US 2017–2021 ($ BILLION)
EXHIBIT 82 US PHARMACEUTICAL R&D EXPENDITURE & ANNUAL GROWTH RATE (%) 2017–2020
EXHIBIT 83 US PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 84 SALES OF PATENTED AND NON-PATENTED DRUGS IN CANADA 2011–2019 ($ BILLIONS)
EXHIBIT 85 HEALTH EXPENDITURE IN CANADA 2011–2019 ($ BILLIONS)
EXHIBIT 86 CANADA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 87 EUROPEAN PHARMACEUTICAL MANUFACTURING VALUE 2019 ($ MILLION)
EXHIBIT 88 PLASTIC PRODUCTION IN EUROPE 2016–2020 (MT)
EXHIBIT 89 TOP FIVE COUNTRIES IN PACKAGING PAPER PRODUCTION 2015–2019
EXHIBIT 90 CONVERTER PLASTICS DEMAND BY COUNTRIES (MT) 2020
EXHIBIT 91 CONVERTERS PLASTICS DEMAND BY TYPES (MT) 2020
EXHIBIT 92 EUROPE PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 93 EUROPE PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 94 EUROPE PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 95 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 96 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 97 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 98 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 99 DRUG SALES IN GERMAN PHARMACEUTICAL MARKET 2019 (IN $ BILLION AND MILLION PACKAGING UNITS)
EXHIBIT 100 PHARMACEUTICAL PRODUCTION IN GERMANY 2015–2018 ($ BILLION)
EXHIBIT 101 GERMANY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 102 UK PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 103 REVENUE OF OTC PHARMACEUTICALS SALES 2017–2021 ($ MILLION)
EXHIBIT 104 PHARMACEUTICAL PACKAGING MARKET IN FRANCE 2021–2027 ($ BILLION)
EXHIBIT 105 BIOSIMILAR CONSUMPTION IN ITALY 2018
EXHIBIT 106 PHARMACEUTICAL INDUSTRY IN ITALY BY NATIONALITY OF OWNERSHIP (% OF TOTAL)
EXHIBIT 107 EXPORT SALES OF PHARMACEUTICAL ITALIAN-OWNED COMPANIES (% OF OVERALL TURNOVER)
EXHIBIT 108 ITALY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 109 OTC PHARMACEUTICALS IN SPAIN: TOTAL REVENUE 2017–2021
EXHIBIT 110 GENERATION OF PLASTIC PACKAGING WASTE IN SPAIN, 2017-2020 (IN 1,000 MT)
EXHIBIT 111 GENERATION OF PLASTIC PACKAGING WASTE IN SPAIN 2017–2020 ( 1,000 MT)
EXHIBIT 112 PHARMACEUTICAL PACKAGING MARKET IN SPAIN 2021–2027 ($ BILLION)
EXHIBIT 113 PHARMACEUTICAL SPENDING BY COUNTRY 2018 ($ BILLION)
EXHIBIT 114 APAC PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 115 APAC PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 116 PHARMACEUTICAL PACKAGING MARKET IN APAC 2021–2027 ($ BILLION)
EXHIBIT 117 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 118 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 119 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 120 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 121 REVENUE SEGMENTATION OF CHINESE PHARMACEUTICAL INDUSTRY 2018 ($ BILLION)
EXHIBIT 122 CHINA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 123 TOTAL PHARMACEUTICALS MARKET ($ THOUSANDS), 2017 - 2020
EXHIBIT 124 PHARMACEUTICAL PACKAGING MARKET IN JAPAN 2021–2027 ($ BILLION)
EXHIBIT 125 DRUG EXPENDITURE DYNAMICS 1995-2020
EXHIBIT 126 SOUTH KOREA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 127 BIOSIMILARS APPROVED BY COUNTRY/REGION, 2019
EXHIBIT 128 INTERNATIONAL TRADE (EXPORT) IN PHARMACEUTICALS ($ BILLION)
EXHIBIT 129 INDIA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 130 AUSTRALIA PLASTIC RECYCLING TARGET 2021
EXHIBIT 131 AUSTRALIA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 132 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 133 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 134 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 135 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 136 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 137 INCREMENTAL GROWTH BY END USER 2021 & 2027
EXHIBIT 138 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 139 PACKAGING PRODUCTION BY MATERIAL IN BRAZIL 2020 (%)
EXHIBIT 140 MAIN PLASTIC RESINS CONSUMED IN BRAZILIAN MARKET 2020 (%)
EXHIBIT 141 BRAZIL PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 142 MEXICO PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 143 PHARMACEUTICAL INDUSTRY SALES 2017–2021 ($ BILLION)
EXHIBIT 144 PHARMACEUTICAL EXPORTS AND IMPORTS 2017–2021 ($ BILLION)
EXHIBIT 145 OTC SALES 2017–2020 (%)
EXHIBIT 146 ARGENTINA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 147 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 148 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET: KEY COUNTRIES 2021 ($ BILLION)
EXHIBIT 149 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 150 INCREMENTAL GROWTH BY TYPE 2021 & 2027
EXHIBIT 151 INCREMENTAL GROWTH BY MATERIAL 2021 & 2027
EXHIBIT 152 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 153 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 154 PERCENTAGE SHARE OF BIOSIMILARS BY THERAPEUTIC AREAS 2020 (%)
EXHIBIT 155 TURKEY PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)
EXHIBIT 156 TURKEY PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)
EXHIBIT 157 TURKEY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 158 SAUDI ARABIA PHARMACEUTICALS MARKET COMPOSITION 2019 ($ BILLION)
EXHIBIT 159 SAUDI ARABIA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 160 SOUTH AFRICA PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
EXHIBIT 161 GLOBAL PHARMACEUTICAL PACKAGING: DIVERSIFIED & PURE PLAYERS
EXHIBIT 162 KEY VENDORS IN PHARMACEUTICAL PACKAGING: MARKET DOMINANCE ANALYSIS
EXHIBIT 163 KEY VENDORS IN PHARMACEUTICAL PACKAGING: CAPABILITIES & EXPERTISE ASSESSMENTS
EXHIBIT 164 AMCOR: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 165 AMCOR: GLOBAL SALES BREAKDOWN 2021 (%)
EXHIBIT 166 AMCOR: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 167 APTARGROUP: TOTAL REVENUE 2019–2021 ($ BILLION)
EXHIBIT 168 APTARGROUP: REVENUE BY PHARMACEUTICAL SEGMENT 2019–2021 ($ BILLION)
EXHIBIT 169 BERRY GLOBAL: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 170 GERRESHEIMER: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 171 WESTROCK: TOTAL REVENUE 2019–2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 ENVIRONMENT IMPACT OF PACKAGING MATERIALS
TABLE 4 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS BETWEEN 2015 AND 2020
TABLE 5 PERCENTAGE SHARE OF VARIOUS BIOPHARMACEUTICALS BETWEEN 2015 AND 2020
TABLE 6 PHARMACEUTICAL PRODUCT RECALLS DUE TO LABELING ERRORS
TABLE 7 ADVANTAGES AND DISADVANTAGES OF RUBBERS
TABLE 8 TOP 5 PAPERBOARD AND PACKAGING PAPER PRODUCTION COUNTRIES 2015–2019 (MT)
TABLE 9 TOP 5 PAPER & PAPERBOARD PRODUCING COUNTRIES 2019 (MILLION MT)
TABLE 10 TOP 3 PAPER & PAPERBOARD CONSUMING APAC COUNTRIES 2019 (MT)
TABLE 11 MEXICO PHARMACEUTICAL MARKET 2018–2020 ($ BILLION)
TABLE 12 MEXICO PLASTIC RESINS PRODUCTION AND MARKET SIZEV2017 – 2020 ($ BILLION)
TABLE 13 AMCOR: MAJOR PRODUCT OFFERINGS
TABLE 14 APTARGROUP: MAJOR PRODUCT OFFERINGS
TABLE 15 BERRY GLOBAL: MAJOR PRODUCT OFFERINGS
TABLE 16 GERRESHEIMER: MAJOR PRODUCT OFFERINGS
TABLE 17 WESTROCK: MAJOR PRODUCT OFFERINGS
TABLE 18 ACG: MAJOR PRODUCT OFFERINGS
TABLE 19 AIRNOV: MAJOR PRODUCT OFFERINGS
TABLE 20 AVI GLOBAL PLAST: MAJOR PRODUCT OFFERINGS
TABLE 21 BD: MAJOR PRODUCT OFFERINGS
TABLE 22 BILCARE: MAJOR PRODUCT OFFERINGS
TABLE 23 BOROSIL: MAJOR PRODUCT OFFERINGS
TABLE 24 CCL INDUSTRIES: MAJOR PRODUCT OFFERINGS
TABLE 25 COESIA: MAJOR PRODUCT OFFERINGS
TABLE 26 DRUG PLASTICS GROUP: MAJOR PRODUCT OFFERINGS
TABLE 27 DWK LIFE SCIENCES: MAJOR PRODUCT OFFERINGS
TABLE 28 LOG: MAJOR PRODUCT OFFERINGS
TABLE 29 MEGHMANI GROUP: MAJOR PRODUCT OFFERINGS
TABLE 30 NEELAM GLOBAL: MAJOR PRODUCT OFFERINGS
TABLE 31 NOLATO: MAJOR PRODUCT OFFERINGS
TABLE 32 NEMERA: MAJOR PRODUCT OFFERINGS
TABLE 33 POLYCINE: MAJOR PRODUCT OFFERINGS
TABLE 34 RENOLIT: MAJOR PRODUCT OFFERINGS
TABLE 35 SCHUR FLEXIBLES HOLDING: MAJOR PRODUCT OFFERINGS
TABLE 36 SPECIALTY POLYFILMS: MAJOR PRODUCT OFFERINGS
TABLE 37 SGD PHARMA: MAJOR PRODUCT OFFERINGS
TABLE 38 SCHOTT: MAJOR PRODUCT OFFERINGS
TABLE 39 SIPPEX IV BAGS: MAJOR PRODUCT OFFERINGS
TABLE 40 SUPER OLEFINS: MAJOR PRODUCT OFFERINGS
TABLE 41 WEST PHARMACEUTICAL SERVICES: MAJOR PRODUCT OFFERINGS
TABLE 42 WIHURI GROUP: MAJOR PRODUCT OFFERINGS
TABLE 43 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 44 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 45 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)
TABLE 46 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)
TABLE 47 GLOBAL PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
TABLE 48 GLOBAL PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)
TABLE 49 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)
TABLE 50 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)
TABLE 51 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 52 GLOBAL PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)
TABLE 53 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)
TABLE 54 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)
TABLE 55 NORTH AMERICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
TABLE 56 NORTH AMERICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)
TABLE 57 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)
TABLE 58 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)
TABLE 59 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 60 NORTH AMERICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)
TABLE 61 EUROPE PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)
TABLE 62 EUROPE PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)
TABLE 63 EUROPE PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
TABLE 64 EUROPE PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)
TABLE 65 EUROPE PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)
TABLE 66 EUROPE PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)
TABLE 67 EUROPE PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 68 EUROPE PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)
TABLE 69 APAC PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)
TABLE 70 APAC PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)
TABLE 71 APAC PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
TABLE 72 APAC PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)
TABLE 73 APAC PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)
TABLE 74 APAC PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)
TABLE 75 APAC PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 76 APAC PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)
TABLE 77 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)
TABLE 78 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)
TABLE 79 LATIN AMERICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
TABLE 80 LATIN AMERICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)
TABLE 81 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)
TABLE 82 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)
TABLE 83 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 84 LATIN AMERICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)
TABLE 85 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 ($ BILLION)
TABLE 86 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY TYPE 2021–2027 (%)
TABLE 87 MIDDLE EAST & AFRICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 ($ BILLION)
TABLE 88 MIDDLE EAST & AFRICA PRIMARY PHARMACEUTICAL PACKAGING MARKET 2021–2027 (%)
TABLE 89 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 ($ BILLION)
TABLE 90 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY MATERIAL 2021–2027 (%)
TABLE 91 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 ($ BILLION)
TABLE 92 MIDDLE EAST & AFRICA PHARMACEUTICAL PACKAGING MARKET BY END USER 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
